These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33332490)

  • 21. Precision Nanomedicine with Bio-Inspired Nanosystems: Recent Trends and Challenges in Mesenchymal Stem Cells Membrane-Coated Bioengineered Nanocarriers in Targeted Nanotherapeutics.
    Baig MS; Ahmad A; Pathan RR; Mishra RK
    J Xenobiot; 2024 Jun; 14(3):827-872. PubMed ID: 39051343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances and clinical challenges of mesenchymal stem cell therapy.
    Mei R; Wan Z; Yang C; Shen X; Wang R; Zhang H; Yang R; Li J; Song Y; Su H
    Front Immunol; 2024; 15():1421854. PubMed ID: 39100671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red blood cells membrane-derived nanoparticles: Applications and key challenges in their clinical translation.
    Malhotra S; Dumoga S; Singh N
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1776. PubMed ID: 35106966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleus-Targeting Manganese Dioxide Nanoparticles Coated with the Human Umbilical Cord Mesenchymal Stem Cell Membrane for Cancer Cell Therapy.
    Xie L; Zhang C; Liu M; Huang J; Jin X; Zhu C; Lv M; Yang N; Chen S; Shao M; Du X; Feng G
    ACS Appl Mater Interfaces; 2023 Mar; 15(8):10541-10553. PubMed ID: 36787533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem/stromal cells as next-generation drug delivery vehicles for cancer therapeutics.
    Takayama Y; Kusamori K; Nishikawa M
    Expert Opin Drug Deliv; 2021 Nov; 18(11):1627-1642. PubMed ID: 34311638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced targeted drug delivery by bioengineered white blood cell-membrane camouflaged nanoparticulate delivery nanostructures.
    Hasan N; Imran M; Jain D; Jha SK; Nadaf A; Chaudhary A; Rafiya K; Jha LA; Almalki WH; Mohammed Y; Kesharwani P; Ahmad FJ
    Environ Res; 2023 Dec; 238(Pt 1):117007. PubMed ID: 37689337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological Cells as Therapeutic Delivery Vehicles.
    Bush LM; Healy CP; Javdan SB; Emmons JC; Deans TL
    Trends Pharmacol Sci; 2021 Feb; 42(2):106-118. PubMed ID: 33342562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual and multi-targeted nanoparticles for site-specific brain drug delivery.
    Luo Y; Yang H; Zhou YF; Hu B
    J Control Release; 2020 Jan; 317():195-215. PubMed ID: 31794799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances in Cell Membrane-Camouflaged Nanoparticles for Cancer Phototherapy.
    Zhen X; Cheng P; Pu K
    Small; 2019 Jan; 15(1):e1804105. PubMed ID: 30457701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal Stem Cells: From Regeneration to Drug Delivery Systems.
    Shokat Z; Ali A; Ahmed U; Javed MR; Qasim M; Tariq M; Ahmed MR; Masoud MS
    Crit Rev Ther Drug Carrier Syst; 2021; 38(3):33-73. PubMed ID: 34348018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell Membranes from Tumor-Tropic MSCs Screened by a Microfluidic Chip for Drug Nanoparticles Encapsulation and Cancer Targeted Therapy.
    Song Y; Shou X; Sheng B; Mei J; Shi K; Shang L; Zhu X
    Adv Healthc Mater; 2023 Jul; 12(17):e2202904. PubMed ID: 36815538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell membrane coated nanoparticles: next-generation therapeutics.
    Narain A; Asawa S; Chhabria V; Patil-Sen Y
    Nanomedicine (Lond); 2017 Nov; 12(21):2677-2692. PubMed ID: 28965474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoy nanoparticles bearing native C5a receptors as a new approach to inhibit complement-mediated neutrophil activation.
    Li Y; Lin F
    Acta Biomater; 2019 Nov; 99():330-338. PubMed ID: 31446047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinspired and Biomimetic Nanomedicines.
    Chen Z; Wang Z; Gu Z
    Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy.
    Hussain Z; Rahim MA; Jan N; Shah H; Rawas-Qalaji M; Khan S; Sohail M; Thu HE; Ramli NA; Sarfraz RM; Abourehab MAS
    J Control Release; 2021 Jul; 335():130-157. PubMed ID: 34015400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review.
    Wei W; Zhang Y; Lin Z; Wu X; Fan W; Chen J
    J Drug Target; 2023 Jan; 31(1):1-13. PubMed ID: 35857432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the synthesis and application of nanoparticles for drug delivery.
    Park W; Na K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(4):494-508. PubMed ID: 25583540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives.
    Regmi S; Pathak S; Kim JO; Yong CS; Jeong JH
    Eur J Cell Biol; 2019 Dec; 98(5-8):151041. PubMed ID: 31023504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system.
    Liu H; Su YY; Jiang XC; Gao JQ
    Drug Deliv Transl Res; 2023 Mar; 13(3):716-737. PubMed ID: 36417162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.